RT Journal Article SR Electronic T1 1507 The Galectin-9-Tim-3 pathway is a novel checkpoint target for patients with biliary tract cancer JF Journal for ImmunoTherapy of Cancer JO J Immunother Cancer FD BMJ Publishing Group Ltd SP A1672 OP A1672 DO 10.1136/jitc-2023-SITC2023.1507 VO 11 IS Suppl 1 A1 Warren, Emilie AK A1 Hammons, Jacklyn A1 Keilson, Jessica A1 Rangel-Rivera, Guillermo O A1 Wyatt, Megan M A1 Goel, Caroline R A1 Henry, Curtis J A1 Kulkarni, Sarah A1 Liu, Yuan A1 Robinson, Brian A1 Krasinskas, Alyssa A1 Maithel, Shishir A1 Paulos, Chrystal M A1 Lesinski, Gregory B YR 2023 UL http://jitc.bmj.com/content/11/Suppl_1/A1672.abstract AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.